NMPA Approval

Composite Potassium Hydrogen Phosphate Injection

Approval Number

国药准字H20253133

Company石家庄四药有限公司

Registration Date

January 14, 2025

Drug Information

Generic Name

复合磷酸氢钾注射液

Dosage Form

注射剂

Strength

5ml：磷酸二氢钾1.12g和磷酸氢二钾（按K₂HPO₄计）1.18g

Drug Type

化学药品

Registration Date

January 14, 2025

Company Information

Applicant Company

Company Name石家庄四药有限公司

Company Address

石家庄高新技术产业开发区槐安东路518号

Manufacturing Company

Company Name石家庄四药有限公司

Company Address

石家庄高新技术产业开发区槐安东路518号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复合磷酸氢钾注射液 - NMPA 批准文号 | MedPath